{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:51:16Z","timestamp":1767135076474,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012191","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000}}],"reference-count":136,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012191.pub2","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T05:47:30Z","timestamp":1556516850000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk-reducing medications for primary breast cancer: a network meta-analysis"],"prefix":"10.1002","volume":"2019","author":[{"given":"Simone","family":"Mocellin","sequence":"first","affiliation":[{"name":"Istituto Oncologico Veneto, IOV-IRCCS; Surgical Oncology Unit; Via Gattamelata 64 Padova Veneto Italy 35128"},{"name":"University of Padova; Department of Surgery Oncology and Gastroenterology; Padova Veneto Italy 35128"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Goodwin","sequence":"additional","affiliation":[{"name":"The University of Sydney, Concord Repatriation General Hospital; Concord Clinical School; Concord NSW Australia 2137"},{"name":"Concord Repatriation General Hospital; Medical Oncology Department; Concord Australia"},{"name":"Sydney Local Health District and South Western Sydney Local Health District; Cancer Genetics Department; Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Pasquali","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Istituto Nazionale dei Tumori; Sarcoma Service; Via G. Venezian 1 Milano Italy 20133"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"issue":"9922","key":"10.1002\/14651858.CD012191.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","article-title":"Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial","volume":"16","author":"Cuzick","year":"2015","journal-title":"Lancet Oncology"},{"issue":"22","key":"10.1002\/14651858.CD012191.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djk050","article-title":"Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial","volume":"99","author":"Powles","year":"2007","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prevention Research"},{"issue":"23","key":"10.1002\/14651858.CD012191.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","author":"ALLHAT Trial Investigators","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/gme.0b013e3181a818db","article-title":"Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women","volume":"16","author":"Archer","year":"2009","journal-title":"Menopause"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2011-1309","article-title":"Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3)and\/or calcium (RECORD trial)","volume":"97","author":"Avenell","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3945\/ajcn.111.015032","article-title":"Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set","volume":"94","author":"Bolland","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"22","key":"10.1002\/14651858.CD012191.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/jnci\/djn360","article-title":"Calcium plus vitamin D supplementation and the risk of breast cancer","volume":"100","author":"Chlebowski","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012191.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"9336","key":"10.1002\/14651858.CD012191.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","article-title":"First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial","volume":"360","author":"Cuzick","year":"2002","journal-title":"Lancet"},{"issue":"23","key":"10.1002\/14651858.CD012191.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2008.19.3797","article-title":"Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women","volume":"27","author":"DeCensi","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD012191.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/annonc\/mdt244","article-title":"A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study","volume":"24","author":"DeCensi","year":"2013","journal-title":"Annals of Oncology"},{"issue":"20","key":"10.1002\/14651858.CD012191.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/dom.12180","article-title":"Observational follow-up of the PROactive study: a 6-year update","volume":"16","author":"Erdmann","year":"2014","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"18","key":"10.1002\/14651858.CD012191.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"12","key":"10.1002\/14651858.CD012191.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/djn153","article-title":"Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk","volume":"100","author":"Grady","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"issue":"21","key":"10.1002\/14651858.CD012191.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/archinte.164.21.2335","article-title":"The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals","volume":"164","author":"Hercberg","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"9681","key":"10.1002\/14651858.CD012191.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD012191.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s00125-010-1804-y","article-title":"Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials","volume":"53","author":"Home","year":"2010","journal-title":"Diabetologia"},{"issue":"9326","key":"10.1002\/14651858.CD012191.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD012191.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamainternmed.2014.3634","article-title":"Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid","volume":"174","author":"Hue","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"22","key":"10.1002\/14651858.CD012191.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/djq415","article-title":"Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women","volume":"102","author":"LaCroix","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial","volume":"85","author":"Lappe","year":"2007","journal-title":"American Journal of Clinical Nutrition"},{"issue":"24","key":"10.1002\/14651858.CD012191.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/jnci\/91.24.2102","article-title":"Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women\u2019s Health Study","volume":"91","author":"Lee","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.294.1.56","article-title":"Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women\u2019s Health Study: a randomized controlled trial","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","author":"LIPID Investigators","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/1940-6207.CAPR-15-0322","article-title":"Double-blind, randomized trial of alternative letrozole dosing regimens in postmenopausal women with increased breast cancer risk","volume":"9","author":"L\u00f3pez","year":"2016","journal-title":"Cancer Prevention Research"},{"issue":"23","key":"10.1002\/14651858.CD012191.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10549-012-2041-5","article-title":"Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene","volume":"134","author":"Powles","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-012-2224-2","article-title":"Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study","volume":"24","author":"Prentice","year":"2013","journal-title":"Osteoporosis International"},{"issue":"14","key":"10.1002\/14651858.CD012191.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"9346","key":"10.1002\/14651858.CD012191.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"9436","key":"10.1002\/14651858.CD012191.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(04)16936-5","article-title":"Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)","volume":"364","author":"Strandberg","year":"2004","journal-title":"Lancet"},{"issue":"7387","key":"10.1002\/14651858.CD012191.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.326.7387.469","article-title":"Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial","volume":"326","author":"Trivedi","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD012191.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/djk154","article-title":"Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy","volume":"99","author":"Veronesi","year":"2007","journal-title":"Journal of the National Cancer Institute"},{"issue":"23","key":"10.1002\/14651858.CD012191.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0042|cit42","first-page":"59","article-title":"Current strategies for the prevention of breast cancer","volume":"6","author":"Advani","year":"2014","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1002\/14651858.CD012191.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/S1470-2045(14)70119-6","article-title":"Statins and breast cancer prognosis: evidence and opportunities","volume":"15","author":"Ahern","year":"2014","journal-title":"Lancet Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12094-014-1250-2","article-title":"Preventive treatments for breast cancer: recent developments","volume":"17","author":"Al\u00e9s-Mart\u00ednez","year":"2015","journal-title":"Clinical & Translational Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/GME.0000000000000426","article-title":"Aromatase inhibitors for prevention of breast cancer in postmenopausal women: a narrative review","volume":"22","author":"Behan","year":"2015","journal-title":"Menopause"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/2046-4053-3-109","article-title":"An overview of conducting systematic reviews with network meta-analysis","volume":"3","author":"Caldwell","year":"2014","journal-title":"Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-013-2505-2","article-title":"Postmenopausal breast cancer, androgens, and aromatase inhibitors","volume":"139","author":"Campagnoli","year":"2013","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","article-title":"Breast cancer. Clinical practice guidelines in oncology","volume":"7","author":"Carlson","year":"2009","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS One"},{"issue":"15","key":"10.1002\/14651858.CD012191.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2002.06.029","article-title":"American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition","volume":"20","author":"Chlebowski","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/187152012799014913","article-title":"Bisphosphonates and breast cancer prevention","volume":"12","author":"Chlebowski","year":"2012","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0054|cit54","first-page":"191","article-title":"Current concepts in breast cancer chemoprevention","volume":"124","author":"Chlebowski","year":"2014","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/IJWH.S69907","article-title":"Clinical utilities of aromatase inhibitors in breast cancer","volume":"7","author":"Chumsri","year":"2015","journal-title":"International Journal of Women's Health"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0057|cit57","first-page":"186","article-title":"Priorities for the primary prevention of breast cancer","volume":"64","author":"Colditz","year":"2014","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.14694\/EdBook_AM.2015.35.e50","article-title":"Addressing barriers to uptake of breast cancer chemoprevention for patients and providers","volume":"35","author":"Crew","year":"2015","journal-title":"American Society of Clinical Oncology Education Book"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnci\/djp018","article-title":"Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk","volume":"101","author":"Cummings","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1470-2045(11)70030-4","article-title":"Preventive therapy for breast cancer: a consensus statement","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncology"},{"issue":"9880","key":"10.1002\/14651858.CD012191.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pop.2014.02.006","article-title":"An update on breast cancer screening and prevention","volume":"41","author":"Cruz","year":"2014","journal-title":"Primary Care"},{"issue":"250","key":"10.1002\/14651858.CD012191.pub2-BIB0063|cit63","first-page":"1","article-title":"Targeted therapy for breast cancer prevention","volume":"3","author":"Hollander","year":"2013","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7","key":"10.1002\/14651858.CD012191.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/bjc.2014.109","article-title":"Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic","volume":"110","author":"Donnelly","year":"2014","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/tbj.12352","article-title":"Breast cancer prevention","volume":"21","author":"Euhus","year":"2015","journal-title":"Breast Journal"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3691","article-title":"The role of vitamin D in reducing cancer risk and progression","volume":"14","author":"Feldman","year":"2014","journal-title":"Nature Reviews Cancer"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012191.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.3747\/co.22.2326","article-title":"Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline","volume":"22","author":"Freedman","year":"2015","journal-title":"Current Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.mcna.2015.01.002","article-title":"Breast cancer screening: an evidence-based update","volume":"99","author":"Fuller","year":"2015","journal-title":"Medical Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/era.11.206","article-title":"Breast cancer chemoprevention","volume":"12","author":"Gabriel","year":"2012","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"pii: djv042","DOI":"10.1093\/jnci\/djv042","article-title":"Twenty-five years of breast cancer risk models and their applications","volume":"107","author":"Gail","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"10.1002\/14651858.CD012191.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prevention Research"},{"issue":"10","key":"10.1002\/14651858.CD012191.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3109\/13880209.2014.988274","article-title":"Vitamin D in cancer chemoprevention","volume":"53","author":"Giammanco","year":"2015","journal-title":"Pharmaceutical Biology"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1123\/jpah.2011-0316","article-title":"Effects of physical activity on breast cancer prevention: a systematic review","volume":"11","author":"Gon\u00e7alves","year":"2014","journal-title":"Journal of Physical Activity & Health"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"448","DOI":"10.6004\/jnccn.2015.0060","article-title":"Breast cancer version 2.2015","volume":"13","author":"Gradishar","year":"2015","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"11","key":"10.1002\/14651858.CD012191.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrclinonc.2013.169","article-title":"Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates","volume":"10","author":"Gronich","year":"2013","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"pii: djv033","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"7414","key":"10.1002\/14651858.CD012191.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0080|cit80","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.14694\/EdBook_AM.2015.35.e59","article-title":"Decision making in the context of breast cancer chemoprevention: patient perceptions and the meaning of risk","volume":"35","author":"Holmberg","year":"2015","journal-title":"American Society of Clinical Oncology Educational Book"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13058-014-0446-2","article-title":"Risk determination and prevention of breast cancer","volume":"16","author":"Howell","year":"2014","journal-title":"Breast Cancer Research"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3892\/or.2014.3270","article-title":"Clinical evidence of the relationship between aspirin and breast cancer risk (review)","volume":"32","author":"Jacobo-Herrera","year":"2014","journal-title":"Oncology Reports"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0085|cit85","first-page":"pii: djw177","article-title":"Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kotsopoulos","year":"2016","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4137\/CGM.S11288","article-title":"Cancer chemoprevention: current state of the art","volume":"7","author":"Landis-Piwowar","year":"2014","journal-title":"Cancer Growth Metastasis"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.breast.2009.08.001","article-title":"Chemoprevention Indication Score: a user-friendly tool for prevention of breast cancer \u2013 pilot analysis","volume":"18","author":"Layeequr Rahman","year":"2009","journal-title":"Breast"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012191.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0960-9776(11)70292-2","article-title":"The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it","volume":"20","author":"Lazzeroni","year":"2011","journal-title":"Breast"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.hoc.2013.05.009","article-title":"Breast cancer prevention by antihormones and other drugs: where do we stand?","volume":"27","author":"Lazzeroni","year":"2013","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.breast.2010.03.013","article-title":"Risk assessment, screening and prevention of breast cancer: a look at cost-effectiveness","volume":"19","author":"Lebovic","year":"2010","journal-title":"Breast"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.2012.651459","article-title":"Aromatase inhibitors and breast cancer prevention","volume":"13","author":"Litton","year":"2012","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.clbc.2012.04.003","article-title":"Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature","volume":"12","author":"Liu","year":"2012","journal-title":"Clinical Breast Cancer"},{"issue":"10","key":"10.1002\/14651858.CD012191.pub2-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002748.pub3","article-title":"Prophylactic mastectomy for the prevention of breast cancer","author":"Lostumbo","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.maturitas.2014.10.010","article-title":"Selective estrogen receptor modulators (SERMs): a review of clinical data","volume":"80","author":"Mirkin","year":"2015","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0095|cit95","first-page":"pii: djv318","article-title":"Breast cancer chemoprevention: a network meta-analysis of randomized controlled trials","volume":"108","author":"Mocellin","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"10","key":"10.1002\/14651858.CD012191.pub2-BIB0096|cit96","first-page":"698","article-title":"Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0097|cit97","first-page":"29","article-title":"Tamoxifen for women at high risk of breast cancer","volume":"6","author":"Nazarali","year":"2014","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1002\/14651858.CD012191.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-158-8-201304160-00005","article-title":"Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Nelson","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0099|cit99","unstructured":"National Institute for health Care Excellence (NICE) Breast cancer risk category https:\/\/www.nice.org.uk\/guidance\/cg164\/chapter\/recommendations#breast-cancer-risk-category 2017"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0100|cit100","first-page":"354","article-title":"Risk-benefit profiles of women using tamoxifen for chemoprevention","volume":"107","author":"Nichols","year":"2014","journal-title":"Journal of the National Cancer Institute"},{"issue":"12","key":"10.1002\/14651858.CD012191.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1177\/1060028014548416","article-title":"Aromatase inhibitors in breast cancer prevention","volume":"48","author":"Olin","year":"2014","journal-title":"Annals of Pharmacotherapy"},{"issue":"19","key":"10.1002\/14651858.CD012191.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/cncr.28771","article-title":"Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level","volume":"120","author":"Onega","year":"2014","journal-title":"Cancer"},{"issue":"13","key":"10.1002\/14651858.CD012191.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2014.1398","article-title":"A systematic assessment of benefits and risks to guide breast cancer screening decisions","volume":"311","author":"Pace","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0104|cit104","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinepi.2014.08.012","article-title":"Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data","volume":"68","author":"Rhodes","year":"2015","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871520614666141020153543","article-title":"BRCA1 as target for breast cancer prevention and therapy","volume":"15","author":"Romagnolo","year":"2014","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"issue":"18","key":"10.1002\/14651858.CD012191.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis","volume":"28","author":"Ropka","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD012191.pub2-BIB0108|cit108","first-page":"6861","article-title":"The role of dietary factors in prevention and progression of breast cancer","volume":"34","author":"Rossi","year":"2014","journal-title":"Anticancer Research"},{"issue":"9826","key":"10.1002\/14651858.CD012191.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Statistical Methods in Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD012191.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"Plos One"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12609-013-0119-7","article-title":"Statins and breast cancer: future directions in chemoprevention","volume":"5","author":"Santa-Maria","year":"2013","journal-title":"Current Breast Cancer Reports"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.hoc.2013.05.004","article-title":"Endocrine therapy for advanced\/metastatic breast cancer","volume":"27","author":"Schiavon","year":"2013","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.molonc.2014.12.006","article-title":"Cancer chemoprevention: much has been done, but there is still much to do. State of the art and possible new approaches","volume":"9","author":"Serrano","year":"2015","journal-title":"Molecular Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GCO.0000000000000153","article-title":"Update on breast cancer risk prediction and prevention","volume":"27","author":"Sestak","year":"2015","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012191.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4292\/wjgpt.v5.i1.40","article-title":"Aspirin, cyclooxygenase inhibition and colorectal cancer","volume":"5","author":"Sostres","year":"2014","journal-title":"World Journal of Gastrointestinal Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0119|cit119","unstructured":"StataCorp LP Stata Statistical Software 2009"},{"issue":"8","key":"10.1002\/14651858.CD012191.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/OGX.0000000000000092","article-title":"Metformin and gynecologic cancers","volume":"69","author":"Stine","year":"2014","journal-title":"Obstetrics & Gynecological Survey"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"dju092","DOI":"10.1093\/jnci\/dju092","article-title":"Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography","volume":"106","author":"Stout","year":"2014","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000369573","article-title":"Medical prevention of breast cancer","volume":"9","author":"Stubert","year":"2014","journal-title":"Breast Care"},{"issue":"6","key":"10.1002\/14651858.CD012191.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11912-013-0351-3","article-title":"Role of aspirin in cancer prevention","volume":"15","author":"Thorat","year":"2013","journal-title":"Current Oncology Reports"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0124|cit124","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10.1002\/14651858.CD012191.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11912-009-0070-y","article-title":"The increasing use of prophylactic mastectomy in the prevention of breast cancer","volume":"12","author":"Tuttle","year":"2010","journal-title":"Current Oncology Reports"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ije\/dys222","article-title":"Evaluation of inconsistency in networks of interventions","volume":"42","author":"Veroniki","year":"2013","journal-title":"International Journal of Epidemiology"},{"issue":"23","key":"10.1002\/14651858.CD012191.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Visvanathan","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12916-015-0300-0","article-title":"Ongoing data from the breast cancer prevention trials: opportunity for breast cancer risk reduction","volume":"13","author":"Vogel","year":"2015","journal-title":"BMC Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/0929867321666141106124315","article-title":"Targeting the NF\u03baB signaling pathways for breast cancer prevention and therapy","volume":"22","author":"Wang","year":"2015","journal-title":"Current Medicinal Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1536867X1101100206","article-title":"Multivariate random-effects meta-regression: updates to mvmeta","volume":"11","author":"White","year":"2011","journal-title":"Stata Journal"},{"issue":"2","key":"10.1002\/14651858.CD012191.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/GCO.0000000000000039","article-title":"The renaissance of endocrine therapy in breast cancer","volume":"26","author":"Williams","year":"2014","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD012191.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/GCO.0000000000000140","article-title":"Clinical management of women at high risk of breast cancer","volume":"27","author":"Wuttke","year":"2015","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012191.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"g3608","DOI":"10.1136\/bmj.g3608","article-title":"An update on the medical management of breast cancer","volume":"348","author":"Yeo","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD012191.pub2-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012191","article-title":"Risk-reducing medication for primary breast cancer: a network meta-analysis","author":"Mocellin","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012191.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T06:03:29Z","timestamp":1711605809000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012191.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Breast Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":136,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012191.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]}}}